Eli Lilly (LLY) Shares Outstanding (2009 - 2026)
Eli Lilly (LLY) reported Shares Outstanding of 892.4 million for Q2 2026, down 0.6% from 897.9 million a year earlier and down 0.2% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Shares Outstanding (2009 - 2026) Analysis & Trends
For FY2025, Eli Lilly posted Shares Outstanding of 897.3 million, down 0.4% from FY2024.
- Shares Outstanding has a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- By year, Shares Outstanding came in at 900.61 million in FY2024 (unchanged), 900.18 million in FY2023 (-0.2%), 901.74 million in FY2022 (-0.6%) and 906.96 million in FY2021 (-0.1%).
- The Q2 2026 figure ranks as the lowest quarterly Shares Outstanding in data going back to Q1 2009.
- Year over year, Shares Outstanding has now declined in each of the last six quarters, with an average decline of 0.3% over the last eight quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at 894.5 million (Q1 2026), 897.3 million (Q4 2025) and 896.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn | 253.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 892.40 Mn |
| Mar 31, 2026 | 894.50 Mn |
| Dec 31, 2025 | 897.30 Mn |
| Sep 30, 2025 | 896.90 Mn |
| Jun 30, 2025 | 897.90 Mn |
| Mar 31, 2025 | 898.70 Mn |
| Dec 31, 2024 | 900.61 Mn |
| Sep 30, 2024 | 901.00 Mn |
| Jun 30, 2024 | 900.90 Mn |
| Mar 31, 2024 | 900.80 Mn |
| Dec 31, 2023 | 900.18 Mn |
| Sep 30, 2023 | 899.80 Mn |
| Jun 30, 2023 | 899.70 Mn |
| Mar 31, 2023 | 901.00 Mn |
| Dec 31, 2022 | 901.74 Mn |
| Sep 30, 2022 | 900.70 Mn |
| Jun 30, 2022 | 900.30 Mn |
| Mar 31, 2022 | 903.70 Mn |
| Dec 31, 2021 | 906.96 Mn |
| Sep 30, 2021 | 906.70 Mn |
API Access
Eli Lilly Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();